M13-300 Effect of food on dasabuvir optimised tablets Ascending M12-351 Comparison of 3 single doses of Single dose paritaprevir SDD Formulation M11-032 Single ascending doses of dasabuvir Multi-dose M10-861 Multiple-ascending doses of paritaprevir M10-687 Multi-dose PKs of dasabuvir M12-187 Multi-dose PKs of ombitasvir and paritaprevir/ritonavir M11-603 PKs of dasabuvir plus paritaprevir/ ritonavir ADME M10-789 ADME of [14C] paritaprevir/ritonavir M12-186 ADME of [14C]ombitasvir PK in Target M10-351 Antiviral activity, and PKs of single and special population multiple doses (2 Days) of dasabuvir popn HCV M11-602 PKs, and antiviral activity of multi-dose Genotype 1 paritaprevir/ ritonavir, dasabuvir, or infected ABT-072 each administered alone subjects Hepatic M12-215 PKs of a single dose of co-administered impairment ombitasvir, dasabuvir, and paritaprevir/ ritonavir M12-193 PKs of a single dose of co-administered impairment ombitasvir, dasabuvir, and paritaprevir/ ritonavir Other M12-221 special PKs of multi-dose of ombitasvir and pop’n paritaprevir/ ritonavir in Han Chinese, Japanese, and Caucasians M12-688 PKs of a single dose of paritaprevir/ ritonavir in Han Chinese, Japanese and Caucasians M12-181 PKs of ombitasvir in Han Chinese, Japanese, and Caucasians M13-505 PKs of the co-formulated paritaprevir/ ritonavir /ombitasvir in Han Chinese and Japanese
M13-300 Effect of food on dasabuvir optimised tablets Ascending Single dose M12-351 Comparison of 3 single doses of paritaprevir SDD Formulation M11-032 Single ascending doses of dasabuvir Multi-dose M10-861 Multiple-ascending doses of paritaprevir M10-687 Multi-dose PKs of dasabuvir M12-187 Multi-dose PKs of ombitasvir and paritaprevir/ritonavir M11-603 PKs of dasabuvir plus paritaprevir/ ritonavir ADME M10-789 ADME of [14C] paritaprevir/ritonavir M12-186 ADME of [14C]ombitasvir PK in special popn Target population HCV Genotype 1 infected subjects M10-351 Antiviral activity, and PKs of single and multiple doses (2 Days) of dasabuvir M11-602 PKs, and antiviral activity of multi-dose paritaprevir/ ritonavir, dasabuvir, or ABT-072 each administered alone Hepatic impairment M12-215 PKs of a single dose of co-administered ombitasvir, dasabuvir, and paritaprevir/ ritonavir impairment M12-193 PKs of a single dose of co-administered ombitasvir, dasabuvir, and paritaprevir/ ritonavir Other special pop’n M12-221 PKs of multi-dose of ombitasvir and paritaprevir/ ritonavir in Han Chinese, Japanese, and Caucasians M12-688 PKs of a single dose of paritaprevir/ ritonavir in Han Chinese, Japanese and Caucasians M12-181 PKs of ombitasvir in Han Chinese, Japanese, and Caucasians M13-505 PKs of the co-formulated paritaprevir/ ritonavir /ombitasvir in Han Chinese and Japanese
auspar-paritaprevir-ritonavir-ombitasvir-dasabuvir-sodium-salt-170324.docx